share_log

Karyopharm Announces Refinancing Transactions $148M Of Existing Convertible Notes Due In 2025 To Be Exchanged for $111M Of New Convertible Notes Due In 2029 And Warrants, Issues New $100M Senior Secured Term Loan Due in 2028a

Karyopharm Announces Refinancing Transactions $148M Of Existing Convertible Notes Due In 2025 To Be Exchanged for $111M Of New Convertible Notes Due In 2029 And Warrants, Issues New $100M Senior Secured Term Loan Due in 2028a

Karyopharm宣布再融资交易2025年到期的现有可转换票据的1.48亿美元将交换2029年到期的1.11亿美元新可转换票据和认股权证,发行2028年到期的1亿美元新优先有担保定期贷款a
Benzinga ·  05/08 07:39

Karyopharm Announces Refinancing Transactions $148M Of Existing Convertible Notes Due In 2025 To Be Exchanged for $111M Of New Convertible Notes Due In 2029 And Warrants, Issues New $100M Senior Secured Term Loan Due in 2028a

Karyopharm宣布再融资交易2025年到期的现有可转换票据的1.48亿美元将交换2029年到期的1.11亿美元新可转换票据和认股权证,发行2028年到期的1亿美元新优先有担保定期贷款a

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发